封面
市場調查報告書
商品編碼
1622108

In Vitro ADME檢驗服務的全球市場規模:各類型,各用途,各地區,範圍及預測

Global In Vitro ADME Testing Services Market Size By Type (Small Molecules, Biologics), By Application (Blood To Plasma Ratio, Metabolic Stability), By Geographic Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

體外 ADME 測試服務市場規模及預測

體外 ADME 測試服務市場規模預計 2024 年為 63.1 億美元,2024 年至 2031 年複合年增長率為 9.29%,預計到 2031 年將達到 128.5 億美元。市場發展得到了針對多種疾病開發新藥的加強研究力度的支持。該研究報告對全球體外 ADME 測試服務市場進行了全面評估。它對關鍵細分市場、趨勢、市場驅動因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

全球體外 ADME 測試服務市場定義

ADME是一個縮寫,指物質和藥物在人體內的吸收、分佈、代謝和排泄,用於藥物動力學和藥理學。此外,了解影響候選化合物功效和安全性的主要理化特徵和結構基序在藥物研究的早期階段至關重要。在體外,ADME 用於確定吸收、分佈、代謝和排泄特性。 ADME 測試對於了解新陳代謝和可能的藥物交互作用至關重要。

此外,對於體外感染,藥物動力學模型可以幫助研究人員更了解抗生素的藥效特性。當與動物和人類藥效學研究結合使用時,它可以為優化給藥方案提供有用的數據。體外模型可用於表徵藥物對細菌族群的影響或取得數據以進行更多分析研究,例如假設檢定。分析研究設計揭示了與預期結果最密切相關的藥效參數和大小。

全球體外 ADME 測試服務市場概覽

由於藥物開發研究資金增加等因素,體外 ADME 測試服務的全球市場正在成長。加強研究力度開發針對多種疾病的新藥有助於市場擴張。此外,隨著慢性、傳染性和遺傳性疾病數量的增加,對有效治療的需求也在增加,從而推動了 ADME 檢測服務的使用。

此外,與使用動物相比,基於培養的生產的簡單性使得體外方法經常成為製藥業大規模生產的選擇方法。抑制全球體外 ADME 檢測服務市場成長的因素包括小鼠腹水法(需要使用小鼠並定期觀察)和體內 MAb 測試(需要使用小鼠進行各種小鼠蛋白質等)。需要淨化的事實。

目錄

第1章 In Vitro ADME檢驗服務的全球市場:簡介

  • 市場概要
  • 調查範圍
  • 前提條件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的調查手法

  • 資料探勘
  • 驗證
  • 一次採訪
  • 資料來源一覽

第4章 In Vitro ADME檢驗服務的全球市場展望

  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 波特的五力分析
  • 價值鏈分析

第5章 In Vitro ADME檢驗服務的全球市場:各類型

  • 概要
  • 低分子
  • 生技藥品

第6章 In Vitro ADME檢驗服務的全球市場:各用途

  • 概要
  • 血漿蛋白質結合
  • 血液/血漿比
  • 代謝穩定性
  • shitokuromu酵素誘導/阻礙

第7章 In Vitro ADME檢驗服務的全球市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 全球其他地區
    • 南美
    • 中東·非洲

第8章 In Vitro ADME檢驗服務的全球市場:競爭情形

  • 概要
  • 企業的市場排行榜
  • 主要的發展策略

第9章 企業簡介

  • Pharmaceutical Product Development
  • Pharmaron
  • Albany Molecular Research
  • Charles River Laboratories
  • Galapagos
  • EnvisionTEC
  • Tecan Group

第10章 附錄

  • 相關調查
簡介目錄
Product Code: 15383

In Vitro ADME Testing Services Market Size And Forecast

In Vitro ADME Testing Services Market size was valued at USD 6.31 Billion in 2024 and is projected to reach USD 12.85 Billion by 2031, growing at a CAGR of 9.29% from 2024 to 2031. The market's expansion is being aided by increased research endeavors to develop novel drugs for several illnesses. The Global In Vitro ADME Testing Services Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global In Vitro ADME Testing Services Market Definition

The abbreviation ADME, which stands for absorption, distribution, metabolism, and elimination of substances and medications in the human body, is used in pharmacokinetics and pharmacology. Furthermore, Understanding the main physicochemical features and structural motifs that influence a compound candidate's effectiveness and safety profile is critical in the early phases of drug research. In vitro, ADME is used to determine absorption, distribution, metabolism, and excretion characteristics. ADME tests are essential for understanding metabolism and possible medication interactions.

Additionally, In vitro infection, pharmacokinetic models can help researchers better understand the pharmacodynamic features of antibacterial drugs. They give data to assist in the optimization of medication dosage regimens when used in conjunction with animal and human pharmacodynamic studies. In vitro models can be used to characterize a drug's effect on a bacterial population or to give data for more analytical research, such as hypothesis testing. Analytical study designs reveal the pharmacodynamic parameter that is most closely linked to the desired outcome, as well as its magnitude.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global In Vitro ADME Testing Services Market Overview

Global In Vitro ADME Testing Services Market is growing because of some factors such as Funding for drug development research has been boosted. The market's expansion is being aided by increased research endeavors to develop novel drugs for several illnesses. In addition, as the number of chronic, infectious, and hereditary disorders rises, so does the need for effective treatments, which promotes the use of ADME Testing services.

Moreover, Because of the simplicity of culture for production compared to the use of animals, in vitro methods are frequently the methods of choice for large-scale manufacturing by the pharmaceutical sector. Some factors hampering the growth of the Global In Vitro ADME Testing Services Market are the mouse ascites approach necessitates the use of mice that must be observed regularly, and In vivo MAb can include a variety of mouse proteins and other pollutants, which may necessitate purification.

Global In Vitro ADME Testing Services Market Segmentation Analysis

The Global In Vitro ADME Testing Services Market is Segmented on the basis of Type, Application, And Geography.

In Vitro ADME Testing Services Market, By Type

  • Small Molecules
  • Biologics

Based on the Type, the market is into Small Molecules and Biologics. Small molecules are majorly helpful to the growth of the market because small compounds offer various benefits over biologics. Small molecules, on the other hand, are more likely to cause harmful non-target effects because biologics are very target-specific and their side effects are mostly related to exaggerated pharmacological effects, whereas biologics are very target-specific and their side effects are mostly related to exaggerated pharmacological effects.

In Vitro ADME Testing Services Market, By Application

  • Plasma Protein Binding
  • Blood to Plasma Ratio
  • Metabolic Stability
  • Cytochrome Enzyme Induction / Inhibition
  • Based on Application, the market is segmented into Plasma Protein Binding, Blood to Plasma Ratio, Metabolic Stability, and Cytochrome Enzyme Induction / Inhibition. Plasma protein binding stakes a major share in the expansion of global In vitro ADME testing services owing to plasma protein bindings are used to measure the potency of a drug which is a very important parameter,

In Vitro ADME Testing Services Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, the Global In Vitro ADME Testing Services Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is anticipated to dominate the Global In Vitro ADME Testing Services Market due to the rapid adoption of newer technologies, and the presence of government rules and regulations which benefits able to the growth of the market.

Key Players

  • The "Global In Vitro ADME Testing Services Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Pharmaceutical Product Development, Pharmaron, Albany Molecular Research, Charles River Laboratories, Galapagos, EnvisionTEC, and Tecan Group.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In December 2021, Color Health, a health technology business dedicated to enhancing public health, and Thermo Fisher Scientific, a world leader in serving research, announced a substantial extension of their partnership. In Texas, the ReadyCheckGo COVID-19 testing system is used in K-12 schools.
  • In February 2020, Catalent, Inc. ("Catalent"), the world's leading provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that Catalent Pharma Solutions, Inc., a wholly-owned subsidiary of Catalent, Inc.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL IN VITRO ADME TESTING SERVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL IN VITRO ADME TESTING SERVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL IN VITRO ADME TESTING SERVICES MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Small Molecules
  • 5.3 Biologics

6 GLOBAL IN VITRO ADME TESTING SERVICES MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Plasma Protein Binding
  • 6.3 Blood to Plasma Ratio
  • 6.4 Metabolic Stability
  • 6.5 Cytochrome Enzyme Induction / Inhibition

7 GLOBAL IN VITRO ADME TESTING SERVICES MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8 GLOBAL IN VITRO ADME TESTING SERVICES MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Pharmaceutical Product Development
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Pharmaron
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Albany Molecular Research
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Charles River Laboratories
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Galapagos
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 EnvisionTEC
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Tecan Group
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments

10 Appendix

  • 10.1 Related Research